{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:01:04Z","timestamp":1769850064239,"version":"3.49.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["JP26293128"],"award-info":[{"award-number":["JP26293128"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.humimm.2016.07.232","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T16:36:20Z","timestamp":1469291780000},"page":"944-951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Involvement of genes encoding apoptosis regulatory factors ( FAS, FASL , TRAIL , BCL2 , TNFR1 and TNFR2 ) in the pathogenesis of autoimmune thyroid diseases"],"prefix":"10.1016","volume":"77","author":[{"given":"Naoya","family":"Inoue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikio","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Ishido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arisa","family":"Kodu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayato","family":"Maruoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Katsumata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoh","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinori","family":"Iwatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2016.07.232_b0005","series-title":"Diagnostic Criteria in Autoimmune Diseases","first-page":"231","article-title":"Graves\u2019 disease","author":"Menconi","year":"2008"},{"key":"10.1016\/j.humimm.2016.07.232_b0010","series-title":"The Thyroid: A Fundamental and Clinical Text","first-page":"721","article-title":"Chronic autoimmune thyroiditis","author":"Weetman","year":"2000"},{"key":"10.1016\/j.humimm.2016.07.232_b0015","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2249.2009.04034.x","article-title":"Association of the-31C\/T functional polymorphism in the interleukin-1beta gene with the intractability of Graves\u2019 disease and the proportion of T helper type 17 cells","volume":"158","author":"Hayashi","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0020","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1365-2249.2010.04306.x","article-title":"Association of functional polymorphisms in promoter regions of IL5, IL6 and IL13 genes with development and prognosis of autoimmune thyroid diseases","volume":"163","author":"Inoue","year":"2011","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0025","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2249.2010.04229.x","article-title":"Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases","volume":"162","author":"Inoue","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0030","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1507\/endocrj.K06-015","article-title":"Association between the severity of Hashimoto\u2019s disease and the functional +874A\/T polymorphism in the interferon-gamma gene","volume":"53","author":"Ito","year":"2006","journal-title":"Endocr. J."},{"key":"10.1016\/j.humimm.2016.07.232_b0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1373\/clinchem.2007.099739","article-title":"The \u2212590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease","volume":"54","author":"Nanba","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.humimm.2016.07.232_b0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-2249.2007.03575.x","article-title":"The +869T\/C polymorphism in the transforming growth factor-beta1 gene is associated with the severity and intractability of autoimmune thyroid disease","volume":"151","author":"Yamada","year":"2008","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0045","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s10875-012-9721-0","article-title":"Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies","volume":"32","author":"Inoue","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0050","series-title":"Normal Mechanisms for Selftolerance","author":"Iwatani","year":"1999"},{"key":"10.1016\/j.humimm.2016.07.232_b0055","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1056\/NEJM200103013440907","article-title":"Tolerance and autoimmunity","volume":"344","author":"Kamradt","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humimm.2016.07.232_b0060","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1074-7613(01)00121-2","article-title":"T cell death and transplantation tolerance","volume":"14","author":"Li","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.humimm.2016.07.232_b0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.181.1.71","article-title":"Fas ligand mediates activation-induced cell death in human T lymphocytes","volume":"181","author":"Alderson","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2016.07.232_b0070","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0167-5699(95)80079-4","article-title":"Fas and FasL in the homeostatic regulation of immune responses","volume":"16","author":"Lynch","year":"1995","journal-title":"Immunol. Today"},{"key":"10.1016\/j.humimm.2016.07.232_b0075","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1046\/j.1365-2443.1996.d01-214.x","article-title":"Fas-induced apoptosis, and diseases caused by its abnormality","volume":"1","author":"Nagata","year":"1996","journal-title":"Genes Cells"},{"key":"10.1016\/j.humimm.2016.07.232_b0080","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.275.5302.960","article-title":"Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto\u2019s thyroiditis","volume":"275","author":"Giordano","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.humimm.2016.07.232_b0085","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/105072504323150723","article-title":"Increased intensities of fas expression on peripheral T-cell subsets in severe autoimmune thyroid disease","volume":"14","author":"Maruoka","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/j.humimm.2016.07.232_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/thy.2006.0231","article-title":"Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases","volume":"17","author":"Nakano","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.humimm.2016.07.232_b0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/thy.1998.8.43","article-title":"Serum concentration of soluble Fas in patients with autoimmune thyroid diseases","volume":"8","author":"Shimaoka","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/j.humimm.2016.07.232_b0100","first-page":"961","article-title":"Increased serum soluble Fas ligand in hyperthyroid Graves\u2019 disease","volume":"47","author":"Takeda","year":"1999","journal-title":"Rinsho Byori"},{"key":"10.1016\/j.humimm.2016.07.232_b0105","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1053\/meta.2002.32034","article-title":"Circulating soluble Fas ligand correlates with disease activity in Graves\u2019 hyperthyroidism","volume":"51","author":"Wang","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/j.humimm.2016.07.232_b0110","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-08-0092","article-title":"Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis","volume":"158","author":"Fountoulakis","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.humimm.2016.07.232_b0115","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1744-313X.2007.00676.x","article-title":"A polymorphism in FAS gene promoter correlated with circulating soluble FAS levels","volume":"34","author":"Mahfoudh","year":"2007","journal-title":"Int. J. Immunogenet."},{"key":"10.1016\/j.humimm.2016.07.232_b0120","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/pros.21328","article-title":"Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population","volume":"71","author":"Shao","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.humimm.2016.07.232_b0125","first-page":"4327","article-title":"Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia","volume":"63","author":"Sibley","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2016.07.232_b0130","doi-asserted-by":"crossref","first-page":"132","DOI":"10.4049\/jimmunol.170.1.132","article-title":"A novel polymorphic CAAT\/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients","volume":"170","author":"Wu","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2567.2009.03058.x","article-title":"Following TRAIL\u2019s path in the immune system","volume":"127","author":"Falschlehner","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.humimm.2016.07.232_b0140","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1210\/en.2005-0627","article-title":"Death ligand tumor necrosis factor-related apoptosis-inducing ligand inhibits experimental autoimmune thyroiditis","volume":"146","author":"Wang","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.humimm.2016.07.232_b0145","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.4049\/jimmunol.0902797","article-title":"Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells","volume":"185","author":"Ikeda","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0150","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10549-010-0900-5","article-title":"Functional implication of TRAIL \u2212716C\/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor","volume":"126","author":"Pal","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.humimm.2016.07.232_b0155","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1158\/0008-5472.CAN-04-2006","article-title":"Bcl-2 overexpression enhances tumor-specific T-cell survival","volume":"65","author":"Charo","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.humimm.2016.07.232_b0160","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ijc.25904","article-title":"Regulatory BCL2 promoter polymorphism (\u2212938C>A) is associated with adverse outcome in patients with prostate carcinoma","volume":"129","author":"Bachmann","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.humimm.2016.07.232_b0165","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.juro.2009.03.081","article-title":"The bcl2 \u2212938CC genotype has poor prognosis and lower survival in renal cancer","volume":"182","author":"Hirata","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.humimm.2016.07.232_b0170","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood-2006-03-007567","article-title":"Association of a novel regulatory polymorphism (\u2212938C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia","volume":"109","author":"Nuckel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.humimm.2016.07.232_b0175","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s004390050847","article-title":"The polymorphic 43Thr bcl-2 protein confers relative resistance to autoimmunity: an analytical evaluation","volume":"103","author":"Komaki","year":"1998","journal-title":"Hum. Genet."},{"key":"10.1016\/j.humimm.2016.07.232_b0180","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1095\/biolreprod.109.082339","article-title":"BCL2 Ala43Thr is a functional variant associated with protection against azoospermia in a Han-Chinese population","volume":"83","author":"Ma","year":"2010","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.humimm.2016.07.232_b0185","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2009.03884.x","article-title":"Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody","volume":"156","author":"Inoue","year":"2009","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0190","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1073\/pnas.87.8.3127","article-title":"Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies","volume":"87","author":"Brockhaus","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.humimm.2016.07.232_b0195","doi-asserted-by":"crossref","first-page":"14927","DOI":"10.1016\/S0021-9258(18)63791-3","article-title":"Two different cell types have different major receptors for human tumor necrosis factor (TNF alpha)","volume":"264","author":"Hohmann","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2016.07.232_b0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/0092-8674(93)90464-2","article-title":"A novel domain within the 55kd TNF receptor signals cell death","volume":"74","author":"Tartaglia","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2016.07.232_b0205","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1126\/science.274.5288.782","article-title":"An essential role for NF-kappaB in preventing TNF-alpha-induced cell death","volume":"274","author":"Beg","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.humimm.2016.07.232_b0210","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1126\/science.7544915","article-title":"TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40","volume":"269","author":"Rothe","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.humimm.2016.07.232_b0215","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1074\/jbc.272.6.3550","article-title":"Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and beta-amyloid toxicity in human neuronal cell line","volume":"272","author":"Shen","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2016.07.232_b0220","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0198-8859(02)00799-1","article-title":"TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes","volume":"64","author":"Nishimura","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0225","doi-asserted-by":"crossref","first-page":"R1227","DOI":"10.1186\/ar1816","article-title":"Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis","volume":"7","author":"Glossop","year":"2005","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.humimm.2016.07.232_b0230","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.182.6.1777","article-title":"Metalloproteinase-mediated release of human Fas ligand","volume":"182","author":"Kayagaki","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2016.07.232_b0235","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nature08402","article-title":"Membrane-bound Fas ligand only is essential for Fas-induced apoptosis","volume":"461","author":"La","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2016.07.232_b0240","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/thy.2008.0423","article-title":"Increases of the Th1\/Th2 cell ratio in severe Hashimoto\u2019s disease and in the proportion of Th17 cells in intractable Graves\u2019 disease","volume":"19","author":"Nanba","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/j.humimm.2016.07.232_b0245","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaci.2010.05.015","article-title":"IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells","volume":"126","author":"Wadsworth","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.humimm.2016.07.232_b0250","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1089\/105072502760339370","article-title":"Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto\u2019s disease","volume":"12","author":"Watanabe","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.humimm.2016.07.232_b0255","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00408-008-9107-5","article-title":"Increased pleural soluble fas ligand (sFasL) levels in tuberculosis pleurisy and its relation with T-helper type 1 cytokines","volume":"186","author":"Budak","year":"2008","journal-title":"Lung"},{"key":"10.1016\/j.humimm.2016.07.232_b0260","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1002\/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2","article-title":"Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: molecular and functional analysis","volume":"44","author":"Morita","year":"2001","journal-title":"Arthritis Rheumatol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916303858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885916303858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T18:34:32Z","timestamp":1656873272000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885916303858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0198885916303858"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2016.07.232","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of genes encoding apoptosis regulatory factors (FAS, FASL, TRAIL, BCL2, TNFR1 and TNFR2) in the pathogenesis of autoimmune thyroid diseases","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2016.07.232","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}